30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Forty Seven Inc (FTSV)

Track

Stock chart
Ticker: FTSV Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
McCamish Mark Anthony
President and CEO
2 sales — total 3,108,504 USD
Sale 1 Apr 2020
Value US$504,417.66 | Price 481.87 | Shares 26,603
Sale 1 Apr 2020
Value US$78,240.22 | Price 236.08 | Shares 71,447
Sale 1 Apr 2020
Value US$3,005,622.07 | Price 114.56 | Shares 62,912
Sale 1 Apr 2020
Value US$7,556,786.90 | Price 95.42 | Shares 79,195
Planned sale 12 Mar 2020
Value US$18,748.00 | Price 93.74 | Shares 200
Planned sale 12 Mar 2020
Value US$3,926,878.38 | Price 93.29 | Shares 42,095
Planned sale 12 Mar 2020
Value US$995,634.72 | Price 92.19 | Shares 10,800
Planned sale 11 Mar 2020
Value US$18,650,211.50 | Price 94.72 | Shares 196,905
Planned sale 18 Feb 2020
Value US$17,202.11 | Price 45.87 | Shares 375
Planned sale 18 Feb 2020
Value US$515,794.58 | Price 45.17 | Shares 11,420
Planned sale 18 Feb 2020
Value US$330,051.66 | Price 44.05 | Shares 7,493
Planned sale 18 Feb 2020
Value US$246,465.95 | Price 43.15 | Shares 5,712
Planned sale 15 Jan 2020
Value US$37,187.01 | Price 36.78 | Shares 1,011
Planned sale 15 Jan 2020
Value US$871,510.77 | Price 36.33 | Shares 23,989
Planned sale 26 Dec 2019
Value US$273,829.70 | Price 44.78 | Shares 6,115
Planned sale 26 Dec 2019
Value US$1,052,850.80 | Price 44.08 | Shares 23,885
Planned sale 16 Dec 2019
Value US$251,225.78 | Price 35.87 | Shares 7,004
Planned sale 16 Dec 2019
Value US$635,942.65 | Price 35.34 | Shares 17,996
Planned sale 10 Dec 2019
Value US$350,000.00 | Price 35.00 | Shares 10,000
Planned sale 9 Dec 2019
Value US$175,645.72 | Price 17.25 | Shares 10,180
Planned sale 9 Dec 2019
Value US$148,763.18 | Price 15.15 | Shares 9,820
Planned sale 9 Dec 2019
Value US$440,000.00 | Price 22.00 | Shares 20,000
Planned sale 9 Dec 2019
Value US$400,000.00 | Price 20.00 | Shares 20,000
Planned sale 9 Dec 2019
Value US$360,000.00 | Price 18.00 | Shares 20,000
Planned sale 9 Dec 2019
Value US$75,000.00 | Price 15.00 | Shares 5,000
Planned sale 9 Dec 2019
Value US$300,000.00 | Price 30.00 | Shares 10,000
Planned sale 20 Nov 2019
Value US$62,500.00 | Price 12.50 | Shares 5,000
Planned sale 18 Nov 2019
Value US$153,915.00 | Price 10.26 | Shares 15,000
Planned sale 16 Aug 2019
Value US$4,215.75 | Price 6.36 | Shares 663
Buy 22 Jul 2019
Value US$1,500,000.00 | Price 8.00 | Shares 187,500
Buy 22 Jul 2019
Value US$4,500,000.00 | Price 8.00 | Shares 562,500
Buy 22 Jul 2019
Value US$2,500,000.00 | Price 8.00 | Shares 312,500
Buy 22 Jul 2019
Value US$2,500,000.00 | Price 8.00 | Shares 312,500
Planned sale 25 Jun 2019
Value US$90,390.70 | Price 11.02 | Shares 8,199
Planned sale 20 Jun 2019
Value US$91,626.44 | Price 11.04 | Shares 8,301
Planned sale 20 May 2019
Value US$16,080.05 | Price 12.46 | Shares 1,291
Planned sale 20 May 2019
Value US$183,645.63 | Price 12.07 | Shares 15,209
Planned sale 16 May 2019
Value US$33,459.99 | Price 16.02 | Shares 2,088
Planned sale 15 May 2019
Value US$35,583.56 | Price 16.01 | Shares 2,223
Planned sale 3 May 2019
Value US$143,951.20 | Price 17.99 | Shares 8,000
Planned sale 26 Apr 2019
Value US$366,978.00 | Price 18.35 | Shares 20,000
Planned sale 18 Apr 2019
Value US$299,054.25 | Price 18.12 | Shares 16,500
Planned sale 15 Apr 2019
Value US$457,505.00 | Price 18.30 | Shares 25,000
Planned sale 5 Apr 2019
Value US$111,799.34 | Price 17.15 | Shares 6,518
Planned sale 4 Apr 2019
Value US$131,104.80 | Price 16.39 | Shares 8,000
Planned sale 3 Apr 2019
Value US$57,632.32 | Price 17.04 | Shares 3,382
Planned sale 29 Mar 2019
Value US$1,800.00 | Price 18.00 | Shares 100
Planned sale 26 Mar 2019
Value US$159,812.00 | Price 15.98 | Shares 10,000
Planned sale 19 Mar 2019
Value US$299,400.75 | Price 18.15 | Shares 16,500
Planned sale 19 Mar 2019
Value US$95,398.35 | Price 18.03 | Shares 5,292
Planned sale 18 Mar 2019
Value US$174,938.16 | Price 18.02 | Shares 9,708
Planned sale 15 Mar 2019
Value US$353,616.00 | Price 17.68 | Shares 20,000
Planned sale 4 Mar 2019
Value US$135,550.40 | Price 16.94 | Shares 8,000
Planned sale 1 Mar 2019
Value US$61,603.26 | Price 17.04 | Shares 3,616
Planned sale 27 Feb 2019
Value US$72,804.94 | Price 17.01 | Shares 4,280
Planned sale 26 Feb 2019
Value US$204,972.77 | Price 16.93 | Shares 12,104
Planned sale 25 Feb 2019
Value US$170,325.00 | Price 17.03 | Shares 10,000
Planned sale 25 Feb 2019
Value US$164,990.02 | Price 16.07 | Shares 10,266
Planned sale 22 Feb 2019
Value US$358,130.63 | Price 16.01 | Shares 22,371
Planned sale 20 Feb 2019
Value US$140,545.88 | Price 14.94 | Shares 9,410
Planned sale 19 Feb 2019
Value US$37,621.25 | Price 15.05 | Shares 2,500
Planned sale 19 Feb 2019
Value US$106,796.67 | Price 15.06 | Shares 7,090
Planned sale 4 Feb 2019
Value US$118,873.60 | Price 14.86 | Shares 8,000
Planned sale 4 Feb 2019
Value US$96,804.54 | Price 15.02 | Shares 6,445
Planned sale 1 Feb 2019
Value US$48,362.26 | Price 15.02 | Shares 3,219
Planned sale 31 Jan 2019
Value US$55,871.73 | Price 14.57 | Shares 3,834
Planned sale 30 Jan 2019
Value US$233,682.76 | Price 14.46 | Shares 16,166
Planned sale 28 Jan 2019
Value US$5,040.74 | Price 15.00 | Shares 336
Planned sale 18 Jan 2019
Value US$291,892.00 | Price 14.59 | Shares 20,000
Planned sale 16 Jan 2019
Value US$69,822.40 | Price 16.00 | Shares 4,363
Planned sale 15 Jan 2019
Value US$361,808.40 | Price 15.73 | Shares 23,000
Planned sale 9 Jan 2019
Value US$170,490.00 | Price 17.05 | Shares 10,000
Planned sale 4 Jan 2019
Value US$124,362.40 | Price 15.55 | Shares 8,000
Planned sale 26 Dec 2018
Value US$157,685.00 | Price 15.77 | Shares 10,000
Planned sale 26 Dec 2018
Value US$47,160.04 | Price 15.89 | Shares 2,968
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-04-03 2020-04-01 S Sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
26,603 -46.5%
481.87
US$504,418 		26,603 -46.5% 481.87 US$504,418
2020-04-03 2020-04-01 S Sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
71,447 +32.8%
236.08
US$78,240 		71,447 +32.8% 236.08 US$78,240
2020-04-03 2020-04-01 S Sale
1.4
RHOADS ANN D

Chief Financial Officer

Officer
62,912 +9.6%
114.56
US$3,005,622 		62,912 +9.6% 114.56 US$3,005,622
2020-04-03 2020-04-01 S Sale
3.4
Takimoto Chris H

Chief Medical Officer

Officer
79,195 -95.3%
95.42
US$7,556,787 		79,195 -95.3% 95.42 US$7,556,787
2020-03-16 2020-03-12 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
200 -0.0%
93.74
US$18,748 		200 -0.0% 93.74 US$18,748
2020-03-16 2020-03-12 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
42,095 -2.3%
93.29
US$3,926,878 		42,095 -2.3% 93.29 US$3,926,878
2020-03-16 2020-03-12 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
10,800 -0.6%
92.19
US$995,635 		10,800 -0.6% 92.19 US$995,635
2020-03-16 2020-03-11 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
196,905 -9.8%
94.72
US$18,650,212 		196,905 -9.8% 94.72 US$18,650,212
2020-02-19 2020-02-18 PlS Planned sale
Majeti Ravindra
Non-Executive Director
375 -0.0%
45.87
US$17,202 		375 -0.0% 45.87 US$17,202
2020-02-19 2020-02-18 PlS Planned sale
Majeti Ravindra
Non-Executive Director
11,420 -1.1%
45.17
US$515,795 		11,420 -1.1% 45.17 US$515,795
2020-02-19 2020-02-18 PlS Planned sale
Majeti Ravindra
Non-Executive Director
7,493 -0.7%
44.05
US$330,052 		7,493 -0.7% 44.05 US$330,052
2020-02-19 2020-02-18 PlS Planned sale
Majeti Ravindra
Non-Executive Director
5,712 -0.5%
43.15
US$246,466 		5,712 -0.5% 43.15 US$246,466
2020-01-16 2020-01-15 PlS Planned sale
Majeti Ravindra
1,011 -0.1%
36.78
US$37,187 		1,011 -0.1% 36.78 US$37,187
2020-01-16 2020-01-15 PlS Planned sale
Majeti Ravindra
23,989 -2.2%
36.33
US$871,511 		23,989 -2.2% 36.33 US$871,511
2019-12-30 2019-12-26 PlS Planned sale WEISSMAN IRVING Non-Executive Director
6,115 -0.3%
44.78
US$273,830 		6,115 -0.3% 44.78 US$273,830
2019-12-30 2019-12-26 PlS Planned sale WEISSMAN IRVING Non-Executive Director
23,885 -1.2%
44.08
US$1,052,851 		23,885 -1.2% 44.08 US$1,052,851
2019-12-17 2019-12-16 PlS Planned sale Majeti Ravindra Non-Executive Director
7,004 -0.6%
35.87
US$251,226 		7,004 -0.6% 35.87 US$251,226
2019-12-17 2019-12-16 PlS Planned sale Majeti Ravindra Non-Executive Director
17,996 -1.6%
35.34
US$635,943 		17,996 -1.6% 35.34 US$635,943
2019-12-11 2019-12-10 PlS Planned sale Takimoto Chris H

Chief Medical Officer

Officer
10,000 -100.0%
35.00
US$350,000 		10,000 -100.0% 35.00 US$350,000
2019-12-10 2019-12-09 PlS Planned sale WEISSMAN IRVING Non-Executive Director
10,180 -0.5%
17.25
US$175,646 		10,180 -0.5% 17.25 US$175,646
2019-12-10 2019-12-09 PlS Planned sale WEISSMAN IRVING Non-Executive Director
9,820 -0.5%
15.15
US$148,763 		9,820 -0.5% 15.15 US$148,763
2019-12-10 2019-12-09 PlS Planned sale Majeti Ravindra Non-Executive Director
20,000 -1.7%
22.00
US$440,000 		20,000 -1.7% 22.00 US$440,000
2019-12-10 2019-12-09 PlS Planned sale Majeti Ravindra Non-Executive Director
20,000 -1.7%
20.00
US$400,000 		20,000 -1.7% 20.00 US$400,000
2019-12-10 2019-12-09 PlS Planned sale Majeti Ravindra Non-Executive Director
20,000 -1.7%
18.00
US$360,000 		20,000 -1.7% 18.00 US$360,000
2019-12-10 2019-12-09 PlS Planned sale Majeti Ravindra Non-Executive Director
5,000 -0.4%
15.00
US$75,000 		5,000 -0.4% 15.00 US$75,000
2019-12-10 2019-12-09 PlS Planned sale Takimoto Chris H

Chief Medical Officer

Officer
10,000 -100.0%
30.00
US$300,000 		10,000 -100.0% 30.00 US$300,000
2019-11-22 2019-11-20 PlS Planned sale Majeti Ravindra Non-Executive Director
5,000 -0.4%
12.50
US$62,500 		5,000 -0.4% 12.50 US$62,500
2019-11-20 2019-11-18 PlS Planned sale
Majeti Ravindra
15,000 -1.2%
10.26
US$153,915 		15,000 -1.2% 10.26 US$153,915
2019-08-21 2019-08-16 PlS Planned sale Takimoto Chris H

Chief Medical Officer

Officer
663 -100.0%
6.36
US$4,216 		663 -100.0% 6.36 US$4,216
2019-07-24 2019-07-22 B Purchase
BIRD JEFFREY W
187,500 +3811.8%
8.00
US$1,500,000 		187,500 +3811.8% 8.00 US$1,500,000
2019-07-24 2019-07-22 B Purchase
BIRD JEFFREY W
562,500 +inf%
8.00
US$4,500,000 		562,500 +inf% 8.00 US$4,500,000
2019-07-24 2019-07-22 B Purchase
Lightspeed Venture Partners X, L.P.
Large shareholder
312,500 +17.5%
8.00
US$2,500,000 		312,500 +17.5% 8.00 US$2,500,000
2019-07-24 2019-07-22 B Purchase
Lightspeed Venture Partners X, L.P.
Large shareholder
312,500 +12.6%
8.00
US$2,500,000 		312,500 +12.6% 8.00 US$2,500,000
2019-06-27 2019-06-25 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
8,199 -11.9%
11.02
US$90,391 		8,199 -11.9% 11.02 US$90,391
2019-06-24 2019-06-20 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
8,301 -12.0%
11.04
US$91,626 		8,301 -12.0% 11.04 US$91,626
2019-05-22 2019-05-20 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
1,291 -2.1%
12.46
US$16,080 		1,291 -2.1% 12.46 US$16,080
2019-05-22 2019-05-20 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
15,209 -20.0%
12.07
US$183,646 		15,209 -20.0% 12.07 US$183,646
2019-05-17 2019-05-16 PlS Planned sale
Majeti Ravindra
2,088 -0.1%
16.02
US$33,460 		2,088 -0.1% 16.02 US$33,460
2019-05-17 2019-05-15 PlS Planned sale
Majeti Ravindra
2,223 -0.2%
16.01
US$35,584 		2,223 -0.2% 16.01 US$35,584
2019-05-07 2019-05-03 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer
8,000 -100.0%
17.99
US$143,951 		8,000 -100.0% 17.99 US$143,951
2019-04-30 2019-04-26 PlS Planned sale
WEISSMAN IRVING
20,000 -1.0%
18.35
US$366,978 		20,000 -1.0% 18.35 US$366,978
2019-04-22 2019-04-18 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
16,500 -21.4%
18.12
US$299,054 		16,500 -21.4% 18.12 US$299,054
2019-04-17 2019-04-15 PlS Planned sale
Majeti Ravindra
25,000 -1.7%
18.30
US$457,505 		25,000 -1.7% 18.30 US$457,505
2019-04-05 2019-04-05 PlS Planned sale
WEISSMAN IRVING
6,518 -0.3%
17.15
US$111,799 		6,518 -0.3% 17.15 US$111,799
2019-04-08 2019-04-04 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer
8,000 -100.0%
16.39
US$131,105 		8,000 -100.0% 16.39 US$131,105
2019-04-05 2019-04-03 PlS Planned sale
WEISSMAN IRVING
3,382 -0.2%
17.04
US$57,632 		3,382 -0.2% 17.04 US$57,632
2019-04-02 2019-03-29 PlS Planned sale
WEISSMAN IRVING
100 -0.0%
18.00
US$1,800 		100 -0.0% 18.00 US$1,800
2019-03-28 2019-03-26 PlS Planned sale
WEISSMAN IRVING
10,000 -0.5%
15.98
US$159,812 		10,000 -0.5% 15.98 US$159,812
2019-03-21 2019-03-19 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
16,500 -21.4%
18.15
US$299,401 		16,500 -21.4% 18.15 US$299,401
2019-03-19 2019-03-19 PlS Planned sale
Majeti Ravindra
5,292 -0.4%
18.03
US$95,398 		5,292 -0.4% 18.03 US$95,398
2019-03-19 2019-03-18 PlS Planned sale
Majeti Ravindra
9,708 -0.7%
18.02
US$174,938 		9,708 -0.7% 18.02 US$174,938
2019-03-19 2019-03-15 PlS Planned sale
Majeti Ravindra
20,000 -1.3%
17.68
US$353,616 		20,000 -1.3% 17.68 US$353,616
2019-03-06 2019-03-04 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer
8,000 -100.0%
16.94
US$135,550 		8,000 -100.0% 16.94 US$135,550
2019-03-05 2019-03-01 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
3,616 -0.2%
17.04
US$61,603 		3,616 -0.2% 17.04 US$61,603
2019-02-27 2019-02-27 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
4,280 -0.2%
17.01
US$72,805 		4,280 -0.2% 17.01 US$72,805
2019-02-27 2019-02-26 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
12,104 -0.6%
16.93
US$204,973 		12,104 -0.6% 16.93 US$204,973
2019-02-27 2019-02-25 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
10,000 -0.5%
17.03
US$170,325 		10,000 -0.5% 17.03 US$170,325
2019-02-26 2019-02-25 PlS Planned sale
Majeti Ravindra
Non-Executive Director
10,266 -0.7%
16.07
US$164,990 		10,266 -0.7% 16.07 US$164,990
2019-02-26 2019-02-22 PlS Planned sale
Majeti Ravindra
Non-Executive Director
22,371 -1.5%
16.01
US$358,131 		22,371 -1.5% 16.01 US$358,131
2019-02-21 2019-02-20 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
9,410 -13.4%
14.94
US$140,546 		9,410 -13.4% 14.94 US$140,546
2019-02-21 2019-02-19 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer

Officer
2,500 -100.0%
15.05
US$37,621 		2,500 -100.0% 15.05 US$37,621
2019-02-21 2019-02-19 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
7,090 -10.5%
15.06
US$106,797 		7,090 -10.5% 15.06 US$106,797
2019-02-05 2019-02-04 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer

Officer
8,000 -100.0%
14.86
US$118,874 		8,000 -100.0% 14.86 US$118,874
2019-02-05 2019-02-04 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
6,445 -0.3%
15.02
US$96,805 		6,445 -0.3% 15.02 US$96,805
2019-02-05 2019-02-01 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
3,219 -0.2%
15.02
US$48,362 		3,219 -0.2% 15.02 US$48,362
2019-02-01 2019-01-31 PlS Planned sale
Majeti Ravindra
Non-Executive Director
3,834 -0.3%
14.57
US$55,872 		3,834 -0.3% 14.57 US$55,872
2019-02-01 2019-01-30 PlS Planned sale
Majeti Ravindra
Non-Executive Director
16,166 -1.1%
14.46
US$233,683 		16,166 -1.1% 14.46 US$233,683
2019-01-30 2019-01-28 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
336 -0.0%
15.00
US$5,041 		336 -0.0% 15.00 US$5,041
2019-01-23 2019-01-18 PlS Planned sale
3.2
McCamish Mark Anthony

President and CEO

Executive Director
20,000 -68.9%
14.59
US$291,892 		20,000 -68.9% 14.59 US$291,892
2019-01-17 2019-01-16 PlS Planned sale
Majeti Ravindra
Non-Executive Director
4,363 -0.3%
16.00
US$69,822 		4,363 -0.3% 16.00 US$69,822
2019-01-17 2019-01-15 PlS Planned sale
Majeti Ravindra
Non-Executive Director
23,000 -1.5%
15.73
US$361,808 		23,000 -1.5% 15.73 US$361,808
2019-01-11 2019-01-09 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
10,000 -0.5%
17.05
US$170,490 		10,000 -0.5% 17.05 US$170,490
2019-01-08 2019-01-04 PlS Planned sale
3.4
Takimoto Chris H

Chief Medical Officer

Officer
8,000 -100.0%
15.55
US$124,362 		8,000 -100.0% 15.55 US$124,362
2019-01-11 2018-12-26 PlS Planned sale
WEISSMAN IRVING
Non-Executive Director
10,000 -0.5%
15.77
US$157,685 		10,000 -0.5% 15.77 US$157,685
2018-12-28 2018-12-26 PlS Planned sale McCamish Mark Anthony

President and CEO

Executive Director
2,968 -24.7%
15.89
US$47,160 		2,968 -24.7% 15.89 US$47,160
Explore more

More insider trading research around Forty Seven Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America